Search Results
You are looking at 1 - 5 of 5 items for
- Author: B Marie x
- Refine by access: All content x
Search for other papers by JC Marie in
Google Scholar
PubMed
Search for other papers by D Bailbe in
Google Scholar
PubMed
Search for other papers by E Gylfe in
Google Scholar
PubMed
Search for other papers by B Portha in
Google Scholar
PubMed
We examined to what extent the abnormal glucose-dependent insulin secretion observed in NIDDM (non-insulin-dependent diabetes mellitus) is related to alterations in the handling of cytosolic Ca2+ of islets of Langerhans. Using two recognized rat models of NIDDM, the GK (Goto-Kakizaki) spontaneous model and the nSTZ (neonatal streptozotocin) induced model, we could detect several common alterations in the glucose-induced [Ca2+]i cytosolic responses. First, the initial reduction of [Ca2+]i following high glucose (16.7 mM) observed routinely in islets obtained from non-diabetic Wistar rats could not be detected in GK and nSTZ islets. Second, a delayed response for glucose to induce a subsequent 3% increase of [Ca2+]i over basal level was observed in both GK (321+/-40 s, n=11) and nSTZ (326+/-38 s, n=13) islets as compared with Wistar islets (198+/-20 s, n=11), values representing means+/-s.e.m. Third, the rate of increase in [Ca2+]i in response to a high glucose challenge was 25% and 40% lower in GK and nSTZ respectively, as compared with Wistar islets. Fourth, the maximal [Ca2+](i) level reached after 10 min of perifusion with 16.7 mM glucose was lower with GK and nSTZ islets and represented respectively 60% and 90% of that of Wistar islets. Further, thapsigargin, a blocker of Ca2+/ATPases (SERCA), abolished the initial reduction in [Ca2+]i observed in response to high glucose and induced fast [Ca2+]i oscillations with high amplitude in Wistar islets. The latter effect was not seen in GK and nSTZ islets. In these two NIDDM models, several common alterations in glucose-induced Ca2+ handling were revealed which may contribute to their poor glucose-induced insulin secretion.
Search for other papers by J.-P. BARLET in
Google Scholar
PubMed
Search for other papers by B. ARGEMI in
Google Scholar
PubMed
Search for other papers by MARIE-JEANNE DAVICCO in
Google Scholar
PubMed
Search for other papers by J. LEFAIVRE in
Google Scholar
PubMed
I.N.R.A., Theix, 63110 Beaumont, France and Groupe Hospitalier de la Timone, 13385 Marseille, France
(Received 31 May 1978)
Very little information is available concerning interrelationships between maternal and foetal concentrations of 25-hydroxy vitamin D3 (25-OHD3; Hillman & Haddad, 1974; Ross, Care, Pickard, Peacock & Robinson, 1976; Weisman, Sapir, Harell & Edelstein, 1976). This paper describes the concentrations of 25-OHD3 in the plasma of pregnant and lactating ewes and their foetal and newborn lambs.
Five ewes bearing single lambs were selected by radiography performed on day 100 of gestation in winter. The daily intakes of calcium, phosphate and magnesium for each animal were respectively, 11, 7 and 2 g. From day 26 pre partum until day 4 post partum, blood samples were collected through catheters implanted on day 115 of gestation in the left foetal and maternal carotid arteries (Mellor & Matheson, 1975). Plasma concentrations of 25-OHD3
Search for other papers by G Skoglund in
Google Scholar
PubMed
Search for other papers by A Basmaciogullari in
Google Scholar
PubMed
Search for other papers by B Rouot in
Google Scholar
PubMed
Search for other papers by JC Marie in
Google Scholar
PubMed
Search for other papers by G Rosselin in
Google Scholar
PubMed
G protein alpha-subunits are involved in the transduction of receptor-mediated regulation of insulin and glucagon secretions. To get further insight into the status of G proteins in alpha- and beta-cells of the Langerhans islets, we have used immunohistochemistry to study the distribution of alpha-subunits in pancreas sections from the rat. Our results show that only insulin-immunoreactive beta-cells display immunoreactivity for selective antibodies directed against the different members of the Galphas and Galpha12-families (alphas, alphaolf, and alpha12, alpha13 respectively). Immunoreactivities for antibodies directed against members of the Galphaq- and Galphai-families showed a more diverse localization: alpha11 and alphao2 were only detected in glucagon-immunoreactive alpha-cells, whereas alphai1 was detected in all beta-cells but only in a few alpha-cells. Even though beta-cells showed immunoreactivities for alphao-non-isoform-selective antibodies, we could not identify the isoform(s) present using selective alphao1 and alphao2 antibodies. Other members of the Galphai- and Galphaq-families (alphai3, alphat2, alphaz and alphaq) were detected in both alpha- and beta-cells. In conclusion, our findings demonstrate a clear difference in the localization of G protein alpha-subunits between alpha- and beta-cells, suggesting the involvement of specific receptor transduction pathways for the neuronal/hormonal regulation of alpha- and beta-cell functions.
Search for other papers by M Klein in
Google Scholar
PubMed
Search for other papers by E Picard in
Google Scholar
PubMed
Search for other papers by JM Vignaud in
Google Scholar
PubMed
Search for other papers by B Marie in
Google Scholar
PubMed
Search for other papers by L Bresler in
Google Scholar
PubMed
Search for other papers by B Toussaint in
Google Scholar
PubMed
Search for other papers by G Weryha in
Google Scholar
PubMed
Search for other papers by A Duprez in
Google Scholar
PubMed
Search for other papers by J Leclere in
Google Scholar
PubMed
Angiogenesis is implicated in several pathological conditions, such as inflammation and tumor growth. Vascular endothelial growth factor (VEGF), also known as vascular permeability factor, is a potent stimulator of endothelial cell proliferation in vitro and in vivo. The present work aimed to compare VEGF expression in human normal thyroid glands, thyroiditis tissue and thyroid carcinomas using immunohistochemistry and in situ hybridization (ISH). Both chronic lymphocytic thyroiditis and differentiated thyroid carcinomas were found to strongly express VEGF mRNA and encode larger amounts of VEGF than normal thyroid tissue as attested by a VEGF immunostaining score. In addition, tumor samples from patients with metastases showed a higher immunostaining score than their non-metastatic counterparts (P<0.05). Carcinomas with the greatest contents of VEGF mRNA and VEGF protein had the most intense mitogenic activity. Special focus on endothelial cells showed intense mitogenic activity in neoplastic tissues in contrast to the total quiescence of endothelial cells in non-tumoral tissues. An intense VEGF production by differentiated thyroid carcinoma, attested either by a higher immunostaining score or a strong VEGF mRNA expression using ISH, could be a promising marker of tumor aggressiveness and may also be useful as a predictor of metastatic potential.
Search for other papers by Linda Vignozzi in
Google Scholar
PubMed
Search for other papers by Annamaria Morelli in
Google Scholar
PubMed
Search for other papers by Erica Sarchielli in
Google Scholar
PubMed
Search for other papers by Paolo Comeglio in
Google Scholar
PubMed
Search for other papers by Sandra Filippi in
Google Scholar
PubMed
Search for other papers by Ilaria Cellai in
Google Scholar
PubMed
Search for other papers by Elena Maneschi in
Google Scholar
PubMed
Search for other papers by Sergio Serni in
Google Scholar
PubMed
Search for other papers by Mauro Gacci in
Google Scholar
PubMed
Search for other papers by Marco Carini in
Google Scholar
PubMed
Search for other papers by Marie-Pierre Piccinni in
Google Scholar
PubMed
Sexual Medicine and Andrology Unit, CIRMAR (Centro Interuniversitario di Ricerca sulle basi molecolari della Malattie della Riproduzione), Department of Anatomy, Interdepartmental Laboratory of Functional and Cellular Pharmacology of Reproduction, Department of Urology, Immunoallergology Unit, Scientific Affairs Men's Healthcare, Gulf Medical University, Intercept Pharmaceuticals Italia Srl, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini 6, Florence 50139, Italy
Search for other papers by Farid Saad in
Google Scholar
PubMed
Search for other papers by Luciano Adorini in
Google Scholar
PubMed
Search for other papers by Gabriella B Vannelli in
Google Scholar
PubMed
Sexual Medicine and Andrology Unit, CIRMAR (Centro Interuniversitario di Ricerca sulle basi molecolari della Malattie della Riproduzione), Department of Anatomy, Interdepartmental Laboratory of Functional and Cellular Pharmacology of Reproduction, Department of Urology, Immunoallergology Unit, Scientific Affairs Men's Healthcare, Gulf Medical University, Intercept Pharmaceuticals Italia Srl, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini 6, Florence 50139, Italy
Search for other papers by Mario Maggi in
Google Scholar
PubMed
Metabolic syndrome (MetS) and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) are often associated. One of their common denominators is hypogonadism. However, testosterone supplementation is limited by concerns for potential prostatic side effects. The objective was to determine whether MetS-associated prostate alterations are prevented by testosterone supplementation. We used a previously described animal model of MetS, obtained by feeding male rabbits a high-fat diet (HFD) for 12 weeks. Subsets of HFD rabbits were treated with testosterone or with the farnesoid X receptor agonist INT-747. Rabbits fed a standard diet were used as controls. HFD-animals develop hypogonadism and all the MetS features: hyperglycemia, glucose intolerance, dyslipidemia, hypertension, and visceral obesity. In addition, HFD-animals show a prostate inflammation. Immunohistochemical analysis demonstrated that HFD-induced prostate fibrosis, hypoxia, and inflammation. The mRNA expression of several proinflammatory (IL8, IL6, IL1β, and TNFα), T lymphocyte (CD4, CD8, Tbet, Gata3, and ROR γt), macrophage (TLR2, TLR4, and STAMP2), neutrophil (lactoferrin), inflammation (COX2 and RAGE), and fibrosis/myofibroblast activation (TGFβ, SM22α, αSMA, RhoA, and ROCK1/ROCK2) markers was significantly increased in HFD prostate. Testosterone, as well as INT-747, treatment prevented some MetS features, although only testosterone normalized all the HFD-induced prostate alterations. Interestingly, the ratio between testosterone and estradiol plasma level retains a significant, negative, association with all the fibrosis and the majority of inflammatory markers analyzed. These data highlight that testosterone protects rabbit prostate from MetS-induced prostatic hypoxia, fibrosis, and inflammation, which can play a role toward the development/progression of BPH/LUTS.
